Patent Foramen Ovale Clinical Trials

Cedars-Sinai Heart Institute is currently conducting the following patent foramen ovale clinical trials:

• The Study Comparing Implant Closure of a Heart Defect called Patent Foramen Ovale (PFO) to Traditional Medical Therapy. "CLOSURE 1"

The Study Comparing Implant Closure of a Heart Defect called Patent Foramen Ovale (PFO) to Traditional Medical Therapy. "CLOSURE 1"

Co-Investigator: Saibal Kar, MD
Principal Investigators: Ravinder Singh, MD

IRB Approval Number: 4133

Contact:Mitch Gheorghiu (310) 423-6152

Recruiting

Summary: The purpose of the Study is to compare the investigational defect closure device (StarFlex) to conventional medical treatment in preventing Stoke or TIA (transient ischemic attack), associated with a heart defect called PFO. The study population includes patients who experienced an index event Stoke or TIA in the previous 6 months, and also have had evidence (by echocardiography) of a PFO. The primary objective is to determine whether the Study device will safely and effectively prevent a recurrent embolic Stoke /TIA and to compare these with that of the best medical treatment (aspirin and the blood thinner: warfarin).